Bivatuzumab mertansine is a combination of bivatuzumab, a humanized monoclonal antibody, and mertansine, a cytotoxic agent.
Bivatuzumab mertansine is a blend of bivatuzumab, a tailored monoclonal antibody, and mertansine, a poisonous compound.